Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672217 · ClinicalTrials.gov registry record · NA
Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT00672217: Completed NA study, sponsored by University of Colorado, Denver.
NCT00672217 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00672217, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The primary goal of the proposed study is to examine a cognitive behavioral intervention for insomnia (CBTI) in women after breast cancer treatment. Chronic Insomnia is a highly prevalent and distressing symptom in cancer patients. CBTI is considered the treatment of choice for chronic primary insomnia. Few studies have been conducted in cancer survivors to evaluate the effect of CBTI on sleep and clinically relevant outcomes.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia (CBTI)
- BEHAVIORAL Behavioral Placebo Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT00672217 record still lists
NCT00672217 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy for Insomnia (CBTI) is the first listed.
NCT00672217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00672217 about?
NCT00672217 is a clinical study titled "Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment". The primary goal of the proposed study is to examine a cognitive behavioral intervention for insomnia (CBTI) in women after breast cancer treatment. Chronic Insomnia is a highly prevalent and distressing symptom in cancer patients. CBTI is considered the treatment of choice for chronic primary insom...
What is the current status of trial NCT00672217?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2008-07. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00672217?
The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (CBTI) (BEHAVIORAL), Behavioral Placebo Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00672217?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00672217's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia